Drug intelligence / Profile preview

ACTV8SKN

Development stage: Unknown
Lead developer: C. Contrad Swiss
Modality: Device-based Delivery → Drug Delivery Systems, Peptides
Administration: Topical

Overview

ACTV8SKN is a regenerative aesthetic product line developed by Contrad Swiss, designed to support skin regeneration, wound healing, and collagenogenesis. The products are powered by SIGMOLECS Technology, a proprietary delivery system engineered by Dr. JO Serrentino, which facilitates the action of biomimetic peptides, hydrolyzed collagen, and hyaluronic acid. ACTV8SKN is primarily used to enhance recovery and results following in-office aesthetic procedures such as laser treatments, microneedling, and chemical peels, but it can also be used as a standalone daily skincare treatment for rejuvenation and hydration. The product line includes the ACTV8SKN Actuator, Lip Volumizer, and Eye Contour.

Brand names: ACTV8SKNACTV-8SKNACTV 8SKNACTV8SKN ActuatorACTV-8SKN ActuatorACTV 8SKN ActuatorACTV8SKN Lip VolumizerACTV-8SKN Lip VolumizerACTV 8SKN Lip VolumizerACTV8SKN Eye ContourACTV-8SKN Eye ContourACTV 8SKN Eye Contour
Other names: ACTV8SKN-Contrad-Regenerative aestheticsACTV-8SKN-Contrad-Regenerative aestheticsACTV 8SKN-Contrad-Regenerative aesthetics

Beyond the preview

Go deeper on ACTV8SKN.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ACTV8SKN.

Explore the full profile